937 Diagnostic, Prognostic, and Pathologic Significance of Cancer Stem Cell Markers CD133 and CD44 in Endometrial Cancers: AI-Assisted Scoring

Abstract

Peer reviewed

Eyas Alzayadneh, Robert Humble, Andrew Bellizzi and Anand Rajan KD

Laboratory investigation, Vol.105(3 Supplement), 103171

03/2025

DOI: 10.1016/j.labinv.2024.103171

View Online

Title: Subtitle: 937 Diagnostic, Prognostic, and Pathologic Significance of Cancer Stem Cell Markers CD133 and CD44 in Endometrial Cancers: AI-Assisted Scoring
Creators: Eyas Alzayadneh - University of Virginia Health System
Robert Humble - University of Michigan
Andrew Bellizzi - University of Iowa
Anand Rajan KD - University of Iowa
Resource Type: Abstract
Publication Details: Laboratory investigation, Vol.105(3 Supplement), 103171
DOI: 10.1016/j.labinv.2024.103171
ISSN: 0023-6837
eISSN: 1530-0307
Publisher: Elsevier Inc
Language: English
Date published: 03/2025
Academic Unit: Pathology
Record Identifier: 9984799677002771

45 Record Views